Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 29 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 10195297

    Iron garnet nanoparticles for cancer radiotherapy and chemotherapy

    The Board of Regents of the University of Texas System · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  2. US 10196450

    Anti-OX40 antibodies and methods of using the same

    The Board of Regents of the University of Texas System · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  3. US 10183011

    Anti-depression compounds

    The Board of Regents of the University of Texas System · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  4. US 10183972

    BK channel-modulating peptides and their use

    The Board of Regents of the University of Texas System · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  5. US 10182997

    Liposomal curcumin for treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  6. US 10172827

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  7. US 10168337

    Method and biomarkers for the detection of dengue hemorrhagic fever

    The Board of Regents of the University of Texas System · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  8. US 10167259

    Allosteric inhibitors of proteasome and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  9. US 10167337

    Combination immunotherapy for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  10. US 10159765

    Tissue engineered devices and methods for making same

    The Board of Regents of the University of Texas System · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  11. US 10154669

    Improving color and release profile of resin compositions comprising silver nanoparticles

    The Board of Regents of the University of Texas System · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted

  12. US 10155003

    Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer

    The Board of Regents of the University of Texas System · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted

  13. US 10150753

    Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyrdin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide

    The Board of Regents of the University of Texas System · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  14. US 10149836

    Isoxazole treatments for frontotemporal dementia

    The Board of Regents of the University of Texas System · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  15. US 10143658

    Multistage delivery of active agents

    The Board of Regents of the University of Texas System · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  16. US 10125128

    GLS1 inhibitors for treating disease

    The Board of Regents of the University of Texas System · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted

  17. US 10126309

    Method for the detection of an albumin isoform

    The Board of Regents of the University of Texas System · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted

  18. US 10125193

    Chimeric antigen receptors and methods of making

    The Board of Regents of the University of Texas System · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted

  19. US 10117878

    Ligands for nematode nuclear receptors and uses thereof

    The Board of Regents of the University of Texas System · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  20. US 10098971

    Library of pH responsive polymers and nanoprobes thereof

    The Board of Regents of the University of Texas System · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  21. US 10098878

    HIF-2α inhibitors for treating iron overload disorders

    The Board of Regents of the University of Texas System · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  22. US 10100317

    Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof

    The Board of Regents of the University of Texas System · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  23. US 10093664

    Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  24. US 10092593

    Citrate-rich calcium-magnesium supplement and uses thereof

    The Board of Regents of the University of Texas System · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.